+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Surgical Heart Valve Repair and Replacement Devices

  • Report
  • 70 Pages
  • July 2021
  • Region: Global
  • MedDeviceTracker
  • ID: 5401761

Overview


This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the surgical heart valve repair (annuloplasty) systems and surgical heart valve replacement products markets for the US, 5 Euro (France, Germany, Italy, Spain, and the UK), Japan, and Rest of World markets from 2020–25. 


The combined global market for surgical heart valve management products totaled nearly $1.8 billion in 2018, with small losses expected over the forecast period covered by this report as less invasive techniques such as TAVR draw market share from open surgical techniques. The US accounted for just over half of surgical heart valve and replacement products sold globally, with the five major EU markets accounting for 22%, Japan accounting for 7%, and the rest of world markets accounting for the remaining sales. 


The COVID-19 pandemic resulted in significantly reduced cardiac procedure volumes in 2020, resulting in related sales declines of up to 10% for many companies. A temporary sales boost is expected in 2021 as many deferred surgeries are rescheduled, followed by a return to typical market trends in subsequent years, with transcatheter techniques drawing market share


Table of Contents

Executive Summary
  • Heart valve disorders overview
  • Global surgical heart valve management market
  • Market drivers and limiters
  • Technology trends
  • Market leaders
  • Methodology
  • Exhibit ES-1: Surgical heart valve management products, combined market forecast, by segment ($m), 2020-25
  • Exhibit ES-2: Surgical heart valve management products, combined market forecast, by region ($m), 2020-25
1. Valvular Heart Disease Overview
1.1 Types of heart valve disorders
1.1.1 Valvular stenosis
1.1.2 Tricuspid valve/pulmonary valve stenosis
1.1.3 Valvular regurgitation
1.2 Conditions associated with heart valve disorders
1.2.1 Congenital defects
1.2.2 Acquired disorders
1.2.3 Calcific degeneration
1.2.4 Infective endocarditis
1.2.5 Rheumatic fever
1.2.6 Heart failure
1.3 Heart valve disorder diagnosis
1.4 Heart valve disease treatment options
1.4.1 Pharmaceutical treatments
1.4.2 Surgical and other interventional solutions
1.5 Bibliography
  • Exhibit 1-1: Progression of valvular heart disease
  • Exhibit 1-2: Euro Heart Survey on Valvular Heart Disease patient population, native heart valve disorders, by type
  • Exhibit 1-3: Types of valvular heart disease and associated conditions of valve disease
2. Surgical Heart Valve Management Products
2.1 Percutaneous balloon valvuloplasty
2.1.1 New and emerging technology
2.2 Heart valve surgery
2.3 Heart valve repair
2.3.1 Products
2.3.2 New and emerging technology
2.4. Heart valve replacement
2.4.1 Valve replacement procedures
2.4.2 Valve replacement materials
2.4.3 Products
2.4.4 Sutureless valves
2.4.5 New and emerging technology
2.5 Bibliography
  • Exhibit 2-1: Potential indications for percutaneous balloon valvuloplasty
  • Exhibit 2-2: Advantages and disadvantages of percutaneous balloon valvuloplasty
  • Exhibit 2-3: Selected percutaneous balloon valvuloplasty systems, 2021
  • Exhibit 2-4: Surgical heart valve repair methods
  • Exhibit 2-5: Advantages of surgical heart valve repair versus replacement
  • Exhibit 2-6: Selected annuloplasty rings, 2021
  • Exhibit 2-7: Selected heart valve replacement products, 2021
3. Surgical Heart Valve Management Products Market
3.1 Global market
3.1.1 Market value
3.1.2 Market drivers and limiters
3.1.3 Surgical versus minimally invasive options
3.2 Surgical heart valve repair products market
3.2.1 US
3.2.2 5 Euro
3.2.3 Japan
3.2.4 Rest of world
3.2.5 Competitive analysis
3.3 Surgical heart valve replacement products market
3.3.1 US
3.3.2 5 Euro
3.3.3 Japan
3.3.4 Rest of world
3.3.5 Competitive analysis
3.4 Bibliography
  • Exhibit 3-1: Surgical heart valve management products, combined market forecast, by segment ($m), 2020-25
  • Exhibit 3-2: Surgical heart valve management products, combined market forecast, by region ($m), 2020-25
  • Exhibit 3-3: Comparison of surgical aortic valve replacement and transcatheter aortic valve replacement
  • Exhibit 3-4: Surgical heart valve repair products, market forecast, by region ($m), 2020-25
  • Exhibit 3-5: Edwards Lifesciences, revenues by segment, FY2020
  • Exhibit 3-6: Medtronic, revenues by segment, FY2020
  • Exhibit 3-7: Abbott, revenues by segment, FY2020
  • Exhibit 3-8: Surgical heart valve repair products market, share by supplier, 2020
  • Exhibit 3-9: Surgical heart valve replacement products, market forecast, by region ($m), 2020-25
  • Exhibit 3-10: LivaNova, revenues by segment, FY2020
  • Exhibit 3-11: Surgical heart valve replacement products market, share by supplier, 2020
Appendix: Company Listing

Companies Mentioned

  • Abbott
  • Edwards Lifesciences
  • LivaNova
  • Medtronic